InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-16 · accession 0001159036-26-000027 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-17 2026-02-16 HALO Snyder Mark Howard SVP, CLO M - OptEx $0.00 +16.8K 39.0K +76% $0
DM 2026-02-17 2026-02-16 HALO Snyder Mark Howard SVP, CLO F - Tax $79.44 -9,068 41.9K -18% -$720.4K
DM 2026-02-17 2026-02-16 HALO Snyder Mark Howard SVP, CLO M - OptEx $0.00 -16.8K 4,796 -78% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-16 M A 12,016 $0.00 48,406 D — —
2 Common Common Stock 2026-02-16 F D 2,587 $79.44 36,390 D — — (F1) The reported disposition of 2,587 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
3 Common Common Stock 2026-02-16 F D 6,481 $79.44 41,925 D — — (F2) The reported disposition of 6,481 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
4 Common Common Stock 2026-02-16 M A 4,796 $0.00 38,977 D — —
5 Derivative Performance Stock Units 2026-02-16 M D 12,016 $0.00 0 D $0.00 · — to — 12,016 Common Stock (F4) This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.
6 Derivative Restricted Stock Units 2026-02-16 M D 4,796 $0.00 4,796 D $0.00 · — to — 4,796 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.